discoveri
function
noncod
rna
led
paradigm
shift
molecular
biolog
past
decad
highlight
import
role
rna
regul
biolog
process
role
previous
allot
protein
appar
rna
carri
genet
inform
protein
product
also
particip
regul
transcript
translat
process
regulatori
function
rna
often
depend
secondari
tertiari
structur
clearli
illustr
natur
occur
metabolit
sensor
riboswitch
riboswitch
structur
noncod
mrna
element
bind
smallmolecul
metabolit
high
affin
specif
regul
transcript
translat
downstream
gene
discoveri
riboswitch
facilit
develop
new
strategi
rna
manipul
small
molecul
includ
natur
synthet
compound
natur
riboswitch
vitroselect
aptam
util
construct
smallmolecul
respons
rna
devic
control
gene
express
cellular
phenotyp
bacteria
yeast
would
highli
desir
develop
small
moleculerespons
rna
devic
mammalian
system
howev
far
limit
success
thu
regul
gene
express
target
rna
synthet
small
molecul
mammalian
system
still
challeng
stateoftheart
synthet
biolog
previous
success
develop
small
molecul
recogn
mismatch
base
pair
doublestrand
dna
rna
molecul
call
naphthyridin
carbam
tetram
nctn
figur
compris
four
heterocycl
connect
flexibl
methylen
linker
heterocycl
possess
hydrogenbond
surfac
complementari
guanin
base
nctn
bind
cggcgg
sequenc
involv
mismatch
flank
base
pair
figur
nctn
mediat
format
complex
two
hairpin
rna
simultan
bind
cgg
sequenc
loop
region
recent
demonstr
nctn
bind
induc
hybrid
cgg
sequenc
two
singlestrand
region
rna
hairpin
one
cgg
motif
loop
tail
therebi
allow
rna
fold
pseudoknot
pseudoknot
structur
motif
commonli
found
ribosom
frameshift
site
mrna
sought
exploit
effect
develop
synthet
platform
regul
translat
given
mrna
mammalian
cell
embed
nctninduc
pseudoknot
sequenc
mrna
therebi
engin
small
moleculeregul
program
ribosom
frameshift
site
translat
recod
mechan
redirect
translat
mrna
altern
read
frame
result
synthesi
two
protein
product
singl
transcript
mani
virus
use
ensur
correct
stoichiometri
protein
requir
replic
contrast
role
eukaryot
system
fulli
understood
signal
regul
express
two
distinct
polypeptid
embryogenesi
produc
truncat
product
may
function
distinct
fulllength
product
caus
prematur
termin
translat
lead
nonsensemedi
mrna
decay
pathway
typic
trigger
two
cisact
mrna
signal
slipperi
sequenc
compris
seven
nucleotid
x
xxi
yyz
frame
indic
space
downstream
secondari
structur
often
rna
pseudoknot
pseudoknot
imped
movement
ribosom
along
mrna
stall
ribosom
precis
slipperi
sequenc
stimul
backward
shift
one
nucleotid
ribosom
resum
decod
unfold
pseudoknot
structur
translat
frame
effici
modul
structur
local
thermodynam
stabil
pseudoknot
base
shown
mutat
studi
pseudoknot
sequenc
also
transact
element
report
modul
frameshift
effici
eg
antisens
oligonucleotid
modul
effici
bind
complementari
sequenc
downstream
slipperi
sequenc
well
stimul
moreov
ribosom
frameshift
stimul
format
gquadruplex
small
moleculestabil
gquadruplex
mrna
howev
clear
whether
small
molecul
use
manipul
stabil
pseudoknot
mrna
thu
determin
ratio
translat
present
studi
found
regul
nctninduc
pseudoknot
demonstr
varieti
differ
vivo
vitro
approach
result
clearli
demonstr
engin
nctninduc
util
increas
product
protein
demand
fusion
partner
via
rnanctn
interact
mrna
contain
renilla
luciferas
rluc
either
truncat
firefli
luciferas
trfluc
tripletag
prepar
follow
adopt
trfluc
mainli
easier
detect
product
respect
construct
see
supplementari
inform
linear
digest
bamhi
use
templat
vitro
transcript
mrna
transcrib
vitro
linear
dna
rna
polymeras
standard
rna
ivt
kit
cellscript
typic
reaction
contain
linear
dna
templat
ng
ntp
atp
ctp
gtp
utp
mm
dtt
mm
enzym
solut
reaction
mixtur
incub
h
follow
digest
templat
dnase
rna
transcript
purifi
column
ge
healthcar
precipit
ammonium
acet
isopropanol
rna
concentr
determin
uv
absorb
rabbit
reticulocyt
lysat
system
promega
use
vitro
translat
mrna
ng
translat
rabbit
reticulocyt
lysat
rrl
contain
amino
acid
mixtur
kcl
mm
reaction
mixtur
incub
h
absenc
presenc
nctn
reaction
quench
ad
sd
buffer
western
blot
analysi
translat
product
translat
mixtur
separ
sdspage
protein
transfer
nitrocellulos
membran
h
v
amersham
ecl
ge
healthcar
use
transblot
sd
semidri
transfer
cell
biorad
blot
block
h
room
temperatur
block
buffer
amersham
ecl
block
agent
trisbuff
salin
contain
tween
ph
tbst
block
blot
probe
h
antibodi
rluc
mbl
ha
tag
wako
flag
tag
mbl
peroxidaseconjug
antibodi
pa
tag
wako
dilut
tbst
solut
get
toyobo
membran
wash
three
time
min
tbst
incub
h
secondari
antibodi
ecl
rabbit
igg
horseradish
peroxidas
conjug
ge
healthcar
dilut
tbst
solut
get
toyobo
immunoreact
band
blot
detect
chemiluminesc
ecl
western
blot
detect
reagent
ge
healthcar
visual
use
system
fujifilm
optic
densiti
band
quantifi
use
imagej
softwar
version
http
rsbinfonihgovij
nation
institut
health
usa
frameshift
effici
fe
calcul
ratio
frameshift
product
fs
sum
fs
nonframeshift
product
nf
use
follow
formula
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
upgreek
usepackag
mathrsf
setlength
oddsidemargin
begin
document
begin
equat
rm
fe
left
right
frac
rm
rm
densiti
rm
rm
fs
rm
band
rm
rm
rm
densiti
rm
rm
fs
rm
band
rm
rm
densiti
rm
rm
nf
rm
band
time
equat
end
document
translat
experi
carri
buffer
rapidli
mix
initi
complex
ribosom
escherichia
coli
mrna
initi
fmettrnafmet
mix
see
supplementari
inform
ternari
complex
consist
elong
factor
tu
eftu
gtp
aminoacyltrna
indic
elong
factor
g
efg
gtp
mm
reaction
stop
addit
koh
peptid
releas
incub
min
neutral
acet
acid
sampl
analyz
hplc
hplc
column
merck
use
gradient
acetonitril
heptafluorobutyr
acid
hfba
elut
time
reaction
product
establish
use
set
model
peptid
synthes
vitro
f
met
gli
fmg
f
metgli
ly
fmgk
f
metgli
ly
ly
fmgkk
f
metgli
ly
lysval
fmgkkv
f
metgli
ly
lysleu
fmgkkl
extent
frameshift
product
fs
nonframeshift
product
nf
determin
amount
f
met
respect
fmgkkv
fmgkkl
peak
sum
fmakk
fmakkv
fmakkl
peptid
end
point
vitro
translat
experi
time
cours
fs
nf
evalu
fit
singl
exponenti
function
use
graphpad
softwar
valu
mean
sd
base
least
three
independ
experi
documentclass
minim
usepackag
amsmath
usepackag
wasysym
usepackag
amsfont
usepackag
amssymb
usepackag
amsbsi
usepackag
upgreek
usepackag
mathrsf
setlength
oddsidemargin
begin
document
begin
equat
rm
fe
frac
rm
f
left
rm
h
right
rm
mgkkv
rm
f
left
rm
h
right
rm
mgkk
rm
f
left
rm
h
right
rm
mgkkv
rm
f
left
rm
h
right
rm
mgkkl
time
equat
end
document
hela
cell
riken
brc
cell
riken
brc
cultur
dulbecco
modifi
eagl
medium
sigma
supplement
vv
fetal
bovin
serum
mp
biomed
addit
nonessenti
amino
acid
solut
ad
medium
cultiv
cell
dual
luciferas
plasmid
see
supplementari
inform
detail
plasmid
construct
transfect
cell
grow
mm
dish
cell
per
dish
use
hd
transfect
reagent
promega
incub
h
cell
distribut
plate
cell
per
well
incub
presenc
nctn
h
dual
luciferas
assay
perform
use
luciferas
assay
system
promega
accord
manufactur
instruct
slight
modif
standard
protocol
chang
follow
aspir
medium
well
twofold
dilut
luciferas
reagent
ad
well
luminesc
measur
use
mithra
micropl
reader
berthold
technolog
product
rlucfluc
fusion
protein
evalu
ratio
fluc
activ
rel
rluc
activ
flucrluc
hela
cell
seed
well
ibidi
densiti
cellswel
cultur
h
transfect
cell
transfect
dualfluoresc
report
plasmid
ng
see
supplementari
inform
detail
plasmid
construct
use
hd
transfect
reagent
incub
h
solut
ad
medium
final
concentr
cell
incub
anoth
h
fluoresc
emgfp
mcherri
observ
confoc
microscop
nikon
excit
nm
nm
respect
fluoresc
intens
fluoresc
protein
local
mitochondria
analyz
use
cell
investig
ge
healthcar
product
mcherryemgfp
fusion
protein
evalu
ratio
emgfp
fluoresc
rel
mcherri
fluoresc
emgfpmcherri
mitochondria
effect
nctn
treatment
cell
viabil
determin
monosodium
salt
assay
kit
dojindo
hela
cell
seed
cellswel
plate
cultur
h
nctn
ad
final
concentr
medium
cell
cultur
h
six
replic
test
concentr
solut
ad
well
plate
incub
sever
hour
measur
absorb
nm
plate
reader
biotek
data
express
percentag
respect
untreat
cell
set
mean
valu
four
replic
design
nctninduc
pseudoknot
sequenc
base
variant
mous
mammari
tumor
viru
mmtv
pseudoknot
vpk
figur
supplementari
figur
caus
gagpro
overlap
mmtv
control
sequenc
full
matchvpk
fvpk
first
obtain
mutat
stem
vpk
bind
site
nctn
creat
stem
fvpk
mutat
obtain
nctninduc
pseudoknot
sequenc
result
construct
addit
mutat
perform
produc
anoth
nctninduc
pseudoknot
sequenc
expect
effici
background
would
reduc
make
stem
less
stabl
without
nctn
addit
construct
design
avpk
neg
control
supplementari
figur
nctnbind
cggcgg
sequenc
replac
aaaaaa
sequenc
stem
nctn
affin
see
effect
nctn
construct
dual
report
system
contain
stimulatori
signal
slipperi
sequenc
aaaaaac
nctninduc
pseudoknot
sequenc
two
report
gene
one
gene
gene
rluc
mcherri
engin
upstream
gene
gene
b
fluc
trfluc
peptid
tag
emgfp
downstream
stimulatori
signal
figur
supplementari
figur
termin
codon
uaa
read
frame
gene
embed
immedi
slipperi
sequenc
order
produc
protein
unless
occur
anticip
nctn
bind
cggcgg
sequenc
dash
box
figur
would
stabil
pseudoknot
structur
downstream
slipperi
sequenc
therebi
increas
effici
product
fusion
protein
b
effici
assess
base
rel
ratio
two
report
protein
first
investig
effect
nctn
effici
analyz
protein
product
obtain
vitro
translat
use
mrna
contain
f
sequenc
rluc
trfluc
figur
absenc
presenc
nctn
translat
product
detect
western
blot
use
antibodi
rluc
figur
supplementari
figur
product
identifi
use
respect
infram
control
mrna
mutat
slipperi
sequenc
onenucleotid
insert
aaaaaac
gaagaagc
give
rise
fulllength
fusion
protein
without
fs
product
lower
mobil
compar
nf
product
sdspage
frameshift
effici
fe
calcul
ratio
fs
product
rel
sum
fs
nf
product
materi
method
among
differ
nctn
compound
increas
fe
promin
supplementari
figur
therefor
investig
effect
detail
supplementari
figur
supplementari
figur
fe
mrna
contain
moder
increas
absenc
presenc
p
figur
also
mrna
contain
sequenc
fe
increas
addit
p
figur
increas
fe
vpk
sequenc
upon
addit
concentr
depend
high
fe
mrna
contain
fvpk
sequenc
due
format
stabl
pseudoknot
structur
regardless
presenc
increas
concentr
amount
fulllength
product
decreas
slightli
suggest
may
small
inhibitori
effect
translat
figur
supplementari
figur
also
confirm
ident
translat
product
obtain
nctninduc
use
tripletag
mrna
contain
ha
tag
frame
flag
tag
frame
pa
tag
frame
sequenc
downstream
frameshift
signal
supplementari
figur
mutat
infram
stop
codon
uaa
downstream
slipperi
sequenc
uac
vpk
pseudoknot
u
avoid
prematur
termin
frame
supplementari
figur
tripletag
mrna
detect
antirluc
antibodi
show
addit
translat
assay
increas
fe
respect
decreas
fe
fvpk
mrna
data
shown
agreement
result
figur
reason
differ
level
observ
experi
shown
figur
supplementari
figur
clear
rule
possibl
mutat
made
frameshift
signal
may
affect
stabil
pseudoknot
structur
frameshift
band
also
detect
antiha
tag
antibodi
supplementari
figur
indic
frameshift
occur
yield
protein
product
ha
peptid
also
identifi
product
frame
use
antiflag
antibodi
supplementari
figur
antipa
antibodi
detect
protein
product
sampl
suggest
ribosom
slip
frame
supplementari
figur
investig
effect
vitro
purifi
translat
system
e
coli
ensur
vitro
translat
modifi
mrna
sequenc
place
initi
codon
two
codon
upstream
slipperi
sequenc
chang
origin
slipperi
sequenc
aaaaaac
aaaaaag
allow
effici
frameshift
e
coli
sequenc
posit
stemloop
kept
origin
vpk
variant
expect
translat
product
frame
metglylyslysleu
mgkkl
frame
metglylyslysv
mgkkv
figur
vitro
translat
assay
contain
purifi
e
coli
trna
glytrnagli
g
lystrnali
k
valtrnav
v
leutrnaleu
l
translat
initi
mix
initi
complex
carri
psite
bound
f
mettrnafmet
excess
ternari
complex
efg
gtp
figur
amount
ternari
complex
optim
ensur
maximum
translat
effici
translat
product
separ
revers
phase
high
perform
liquid
chromatographi
rp
hplc
peak
posit
identifi
use
radioactivelabel
f
k
l
v
figur
determin
fe
mgkkv
ratio
frameshift
peak
sum
mgkk
mgkkv
mgkkl
peak
end
point
translat
reaction
figur
absenc
fe
construct
similar
mrna
variant
avpk
highest
fe
observ
mrna
contain
fvpk
sequenc
figur
supplementari
tabl
due
presenc
stabl
pseudoknot
regardless
presenc
presenc
fe
increas
contrast
fe
avpk
fvpk
chang
respect
figur
supplementari
tabl
increas
concentr
shown
similar
fe
level
data
shown
identifi
whether
affect
kinet
translat
perform
codon
walk
experi
quantifi
percentag
translat
ribosom
frame
time
point
absenc
rate
frame
translat
slow
incorpor
frame
val
neglig
figur
supplementari
tabl
presenc
rate
frame
mgkkl
format
slightli
faster
without
wherea
rate
frame
mgkkv
much
higher
absenc
drug
figur
supplementari
tabl
fvpk
mrna
variant
presenc
absenc
figur
rate
frame
frame
translat
unchang
respect
supplementari
tabl
similarli
avpk
mrna
presenc
absenc
chang
rate
effici
translat
mgkkv
mgkkl
expect
result
suggest
modul
frameshift
act
base
stem
downstream
mrna
structur
lead
increas
frame
val
incorpor
next
examin
whether
nctn
induc
cell
addit
construct
describ
f
avpk
produc
two
variant
supplementari
figur
mrna
variant
contain
ochr
termin
codon
uaa
end
rluc
gene
repress
translat
downstream
fluc
gene
figur
mrna
variant
nonslipperi
gcgcgcg
sequenc
instead
slipperi
aaaaaac
sequenc
nctninduc
pseudoknot
sequenc
stem
unchang
examin
effect
nctn
use
dual
luciferas
mrna
measur
cell
viabil
nctn
treatment
assess
potenti
toxic
effect
nctn
determin
appropri
concentr
rang
exposur
hela
cell
differ
concentr
nctn
result
reduct
cell
viabil
supplementari
figur
calcul
valu
cell
viabil
thu
evalu
effect
nctn
cell
concentr
rang
hela
cell
transfect
dual
luciferas
construct
treat
indic
concentr
figur
frameshift
effici
fe
determin
divid
flucrluc
activ
ratio
obtain
mutant
construct
ratio
obtain
correspond
infram
control
cell
express
sequenc
fe
increas
absenc
increas
fe
increas
fe
also
seen
construct
fe
absenc
presenc
fe
cell
express
fvpk
chang
significantli
increas
concentr
chang
fe
rel
background
cell
express
treat
respect
much
higher
fvpk
express
cell
suggest
effect
fe
cell
express
target
sequenc
exclud
possibl
activ
cryptic
promot
dual
luciferas
construct
nonspecif
increas
express
level
fluc
gene
gener
promot
delet
version
supplementari
figur
dual
luciferas
construct
measur
rluc
fluc
activ
cell
transfect
promot
delet
construct
transfect
promot
delet
construct
hela
cell
show
minim
background
luminesc
rluc
fluc
treatment
increas
luciferas
activ
argu
effect
activ
cryptic
promot
dual
luciferas
construct
also
analyz
transcript
rtpcr
examin
whether
induc
aberr
splice
event
might
affect
luciferas
activ
supplementari
figur
presenc
absenc
promot
major
amplifi
product
bp
correspond
fulllength
cdna
fragment
rule
possibl
observ
increas
fluc
activ
caus
aberr
splice
event
andor
cryptic
promot
activ
upon
treatment
effect
also
investig
construct
supplementari
figur
effect
nctn
shown
flucrluc
activ
ratio
due
lack
respect
avail
infram
construct
cell
express
avpk
sequenc
show
low
flucrluc
ratio
independ
concentr
supplementari
figur
panel
cell
express
sequenc
flucrluc
ratio
increas
dosedepend
manner
supplementari
figur
panel
b
result
indic
effect
increas
flucrluc
ratio
depend
pseudoknotform
sequenc
mrna
flucrluc
ratio
sequenc
affect
addit
supplementari
figur
panel
e
suggest
slipperi
sequenc
addit
cggcgg
sequenc
essenti
increas
translat
fluc
introduct
termin
codon
infram
rluc
gene
suppress
supplementari
figur
panel
f
result
exclud
possibl
presenc
altern
translat
start
site
fluc
nctn
deriv
also
effect
increas
flucrluc
ratio
hela
cell
supplementari
figur
naphthyridin
carbam
dimer
contain
partial
structur
nctn
increas
flucrluc
ratio
supplementari
figur
therebi
exclud
possibl
nonspecif
effect
synthet
compound
compar
result
show
increas
flucrluc
ratio
concentr
depend
manner
obtain
use
cell
supplementari
figur
overal
result
strongli
suggest
nctn
modul
event
human
cell
bind
sequenc
form
nctnstabil
pseudoknot
structur
evalu
nctninduc
system
directli
detect
express
report
protein
cell
design
dualfluoresc
report
construct
contain
mcherri
gene
coupl
mitochondri
local
signal
ml
upstream
gene
emgfp
gene
downstream
gene
b
figur
expect
mcherri
fluoresc
would
mainli
observ
mitochondria
without
wherea
mcherri
emgfp
fluoresc
would
observ
mitochondria
activ
ad
local
fluoresc
protein
hela
cell
observ
confoc
fluoresc
microscopi
emgfpmcherri
ratio
calcul
accord
intens
emgfp
fluoresc
rel
mcherri
fluoresc
mitochondria
addit
hela
cell
express
sequenc
induc
express
emgfp
coloc
mcherri
mitochondria
figur
emgfpmcherri
ratio
presenc
time
higher
background
figur
light
blue
box
increas
express
coloc
emgfp
mcherri
also
observ
cell
transfect
construct
figur
emgfpmcherri
ratio
increas
time
compar
background
absenc
figur
magenta
box
cell
express
fvpk
sequenc
mcherri
emgfp
fluoresc
detect
mitochondria
regardless
presenc
figur
emgfpmcherri
ratio
obtain
randomli
select
cell
clearli
indic
effect
hela
cell
transfect
construct
statist
signific
p
student
ttest
figur
thu
oper
human
cell
studi
success
demonstr
synthet
molecul
nctn
modul
rna
secondari
structur
activ
therebi
induc
synthesi
protein
altern
read
frame
vitro
translat
system
mammalian
cell
design
nctn
allow
sitespecif
modul
rna
secondari
structur
wide
rang
organ
ligandinduc
system
four
characterist
enabl
ligandmedi
upregul
target
gene
translat
level
ribosom
frameshift
allow
rapid
respons
stimuli
term
gene
express
compar
slower
respons
mediat
via
transcript
regul
ii
allow
condit
express
target
protein
ligand
benefit
use
smallmolecul
ligand
condit
regul
gene
express
translat
level
convincingli
demonstr
synthet
riboswitch
studi
iii
would
technic
possibl
induc
de
novo
product
fusion
protein
ligand
therebi
increas
fraction
fusion
protein
speci
cell
respons
presenc
absenc
ligand
nctninduc
use
express
type
protein
fusion
partner
transcript
factor
local
signal
peptid
degron
transport
protein
specif
target
protein
therebi
provid
numer
possibl
new
protein
express
engin
design
iv
system
quit
simpl
requir
two
compon
ie
nctn
rna
contain
slipperi
sequenc
nctninduc
pseudoknot
allow
applic
simpler
organ
induc
gene
express
system
current
avail
futur
sensit
applic
system
tune
eg
increas
effici
reduc
background
use
sequenc
overal
present
studi
describ
simpl
tool
reprogram
cellular
gene
express
respons
small
synthet
molecul
anticip
structur
nctn
rna
sequenc
optim
order
reduc
sideeffect
cytotox
nctn
practic
applic
higher
organ
studi
provid
proofofprincipl
uniqu
simpl
strategi
regul
ribosom
read
frame
select
use
small
synthet
molecul
furthermor
find
show
small
synthet
molecul
use
target
rna
regul
function
rna
mammalian
cell
facilit
develop
rnatarget
drug
foster
futur
applic
biolog
medicin
chemistri
